Pages
- 3D Cell Culture
- About
- About Organ-On-Chip
- Barrier Models
- Brochures
- Careers
- Consumables
- Contact
- COVID-19 Research
- Disease Modelling
- Drug Metabolism
- Drug Metabolism and Safety Toxicity Testing Services
- Events
- Happy Holidays
- Home
- Human Cell Referral
- Jobs
- LC12
- Liver-On-Chip
- NASH Fee-For-Service
- News
- PhysioMimix™ OOC
- Privacy
- Roche
- Scientific Publications
- Sitemap
- SOT 2020
- SOT 2021
- T12
- Terms and Conditions
- Toxicology
- Videos
- Virtual Analytical Summit 2020
Easy HTML Sitemap Plugin by WebsiteBuilderGuide
Posts
- Al Jazeera
- BBC World Service
- Bloomberg
- Bloomberg
- Bloomberg
- Bloomberg and Businessweek feature CN Bio Innovations’ LiverChip Platform
- CN Bio and Cambridge University identify novel regulatory pathway driving NASH
- CN Bio and Imperial College London Collaboration
- CN Bio and MIT announce 10 Organ-On-Chip Platform: Nature Scientific Reports
- CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients
- CN Bio announces opening of new Biosafety Level 3 facility
- CN Bio announces research collaboration with antisense discovery pioneers Isis Pharmaceuticals
- CN Bio announces research collaboration with gene silencing specialist Benitec Biopharma
- CN Bio appoints Dr David Hughes to board of directors
- CN Bio appoints Emma Sceats as CEO
- CN Bio appoints Professor Mark Thursz as Scientific Advisor
- CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research
- CN Bio featured on the Discovery Channel
- CN Bio hires Director of Licensing
- CN Bio hosts popular Investigator Meeting and presents new HBV data at AASLD 2014
- CN Bio Innovations announces deal with sixth pharmaceutical collaborator in 2015 and features in The Economist
- CN Bio Innovations announces Hepatitis B research collaboration with leading pharmaceutical company
- CN Bio Innovations announces licence of platform microfluidics technologies from Vanderbilt University
- CN Bio Innovations announces license of worldwide rights to Hepatitis B programme from Bristol-Myers Squibb
- CN Bio Innovations announces LiverChip research study with leading pharmaceutical company
- CN Bio Innovations announces research collaboration with Alnylam
- CN Bio Innovations announces research collaboration with AstraZeneca to validate a new in vitro tool to predict optimised drug dosing regimens for multi-drug therapies
- CN Bio Innovations features in Al Jazeera documentary “The Cure”
- CN Bio Innovations marks World Hepatitis Day by signing research agreement with Imperial College London
- CN Bio Innovations raises $9 million USD (c. £6.9 million GBP)
- CN Bio Innovations’ Board names David Hughes as next Chief Executive Officer
- CN Bio launches PhysioMimix benchtop Human-Body-on-a-Chip device
- CN Bio makes key senior appointments to support international commercial development
- CN Bio MicroMix to be featured at AACR
- CN Bio Sponsors the Organ-On-Chip world congress in Boston
- CN Bio to bring 10 organs together on a chip
- CN Bio to provide drug metabolism and safety toxicity testing services
- CN Bio’s PhysioMimix™ technology receives FDA recognition
- Dr Emma Sceats of organ-on-a-chip firm CN Bio Innovations wins Innovate UK’s infocus Women in Innovation award
- FDA signs collaborative agreement with CN Bio Innovations to use Organs-on-Chips to improve drug development and evaluation
- Flowing to the Beat of Your Heart
- Hepatitis B research using CN Bio Organ-on-Chips published in Nature Communications
- How a novel <em>in vitro</em> Liver-on-a-Chip model of fatty liver disease is being used to help prevent a global healthcare crisis.
- Huffington Post features CN Bio
- Imperial College London to present first public HBV data from CN Bio in vitro liver model
- Imperial College London to present HBV data on CN Bio immune-competent liver model at AASLD The Liver Meeting
- Innovate UK awards grant to CN Bio Innovations and AstraZeneca to use Organs-on-Chips to evaluate the use of existing drugs to treat fatty liver disease
- Life in the Fastlane
- Liver disease to become a bigger killer than heart disease or cancer
- MIT and CN Bio to showcase world’s first 7 organ “Human-on-a-Chip” at Organ-On-Chip congress
- NASH Drug Discovery Service Launched at AASLD
- NIH Director highlights LiverChip in Compton Lecture
- Organ-on-Chip Webinar: Improving Preclinical Studies for Faster Drug Development
- PharmaVentures Interview: Will Organ-on-Chip technology provide the data Regulators need in the future?
- PhysioMimix™ Human 3D Cell Culture wins Lab Innovation 2018 Award
- Promotion of Dr David Hughes to the role of Chief Technology Officer
- R&D 100 Award won by Vanderbilt team for tech being developed with CN Bio
- Radio 4’s PM features CN Bio Human Organ-on-Chips
- Sydney’s AXT offers Organ-on-Chip systems in Asia Pacific region
- The Economist
- TSB Funds New Research by CN Bio into Fatty Liver Disease
- Zyoxel Ltd to become CN Bio Innovations Ltd
Easy HTML Sitemap Plugin by WebsiteBuilderGuide